262 related articles for article (PubMed ID: 10212126)
1. Chicoric acid analogues as HIV-1 integrase inhibitors.
Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors.
Meadows DC; Mathews TB; North TW; Hadd MJ; Kuo CL; Neamati N; Gervay-Hague J
J Med Chem; 2005 Jul; 48(14):4526-34. PubMed ID: 15999991
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel hybrid dicaffeoyltartaric/diketo acid and tetrazole-substituted L-chicoric acid analogue inhibitors of human immunodeficiency virus type 1 integrase.
Crosby DC; Lei X; Gibbs CG; McDougall BR; Robinson WE; Reinecke MG
J Med Chem; 2010 Nov; 53(22):8161-75. PubMed ID: 20977258
[TBL] [Abstract][Full Text] [Related]
5. Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors.
Lee SU; Shin CG; Lee CK; Lee YS
Eur J Med Chem; 2007 Oct; 42(10):1309-15. PubMed ID: 17434650
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase.
Charvat TT; Lee DJ; Robinson WE; Chamberlin AR
Bioorg Med Chem; 2006 Jul; 14(13):4552-67. PubMed ID: 16524737
[TBL] [Abstract][Full Text] [Related]
7. A docking study of L-chicoric acid with HIV-1 integrase.
Healy EF; Sanders J; King PJ; Robinson WE
J Mol Graph Model; 2009 Jan; 27(5):584-9. PubMed ID: 19004651
[TBL] [Abstract][Full Text] [Related]
8. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
[TBL] [Abstract][Full Text] [Related]
9. Arylamide inhibitors of HIV-1 integrase.
Zhao H; Neamati N; Mazumder A; Sunder S; Pommier Y; Burke TR
J Med Chem; 1997 Apr; 40(8):1186-94. PubMed ID: 9111292
[TBL] [Abstract][Full Text] [Related]
10. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
[TBL] [Abstract][Full Text] [Related]
11. Catechol-substituted L-chicoric acid analogues as HIV integrase inhibitors.
Lee JY; Yoon KJ; Lee YS
Bioorg Med Chem Lett; 2003 Dec; 13(24):4331-4. PubMed ID: 14643320
[TBL] [Abstract][Full Text] [Related]
12. L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro.
Reinke RA; Lee DJ; McDougall BR; King PJ; Victoria J; Mao Y; Lei X; Reinecke MG; Robinson WE
Virology; 2004 Sep; 326(2):203-19. PubMed ID: 15302207
[TBL] [Abstract][Full Text] [Related]
13. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
[TBL] [Abstract][Full Text] [Related]
14. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters.
Pluymers W; Neamati N; Pannecouque C; Fikkert V; Marchand C; Burke TR; Pommier Y; Schols D; De Clercq E; Debyser Z; Witvrouw M
Mol Pharmacol; 2000 Sep; 58(3):641-8. PubMed ID: 10953059
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
[TBL] [Abstract][Full Text] [Related]
16. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase.
Du L; Zhao YX; Yang LM; Zheng YT; Tang Y; Shen X; Jiang HL
Acta Pharmacol Sin; 2008 Oct; 29(10):1261-7. PubMed ID: 18817633
[TBL] [Abstract][Full Text] [Related]
17. Hydrazide-containing inhibitors of HIV-1 integrase.
Zhao H; Neamati N; Sunder S; Hong H; Wang S; Milne GW; Pommier Y; Burke TR
J Med Chem; 1997 Mar; 40(6):937-41. PubMed ID: 9083482
[TBL] [Abstract][Full Text] [Related]
18. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
[TBL] [Abstract][Full Text] [Related]
19. Dicaffeoyltartaric acid analogues inhibit human immunodeficiency virus type 1 (HIV-1) integrase and HIV-1 replication at nontoxic concentrations.
Reinke RA; King PJ; Victoria JG; McDougall BR; Ma G; Mao Y; Reinecke MG; Robinson WE
J Med Chem; 2002 Aug; 45(17):3669-83. PubMed ID: 12166940
[TBL] [Abstract][Full Text] [Related]
20. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
Mekouar K; Mouscadet JF; Desmaële D; Subra F; Leh H; Savouré D; Auclair C; d'Angelo J
J Med Chem; 1998 Jul; 41(15):2846-57. PubMed ID: 9667973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
